Which tumor marker is elevated in medullary thyroid carcinoma?

Prepare for the Endocrine Disorder Test. Engage with multiple choice questions with hints and explanations, ensuring a thorough understanding of endocrine system concepts. Excel in your exam with confidence!

Multiple Choice

Which tumor marker is elevated in medullary thyroid carcinoma?

Explanation:
Medullary thyroid carcinoma arises from parafollicular C cells that secrete calcitonin, so calcitonin levels in the blood are typically elevated and serve as a useful marker for diagnosis and for monitoring response to treatment or recurrence after surgery. This marker directly reflects the tumor’s biology, making it the most informative indicator in this cancer. Thyroglobulin is produced by follicular cells and is mainly a marker for differentiated thyroid cancers such as papillary or follicular types, so it isn’t reliable for medullary carcinoma. CEA can be elevated in medullary thyroid carcinoma but is nonspecific and less helpful for direct disease monitoring. Calcitonin gene-related peptide isn’t used clinically as a tumor marker for this cancer.

Medullary thyroid carcinoma arises from parafollicular C cells that secrete calcitonin, so calcitonin levels in the blood are typically elevated and serve as a useful marker for diagnosis and for monitoring response to treatment or recurrence after surgery. This marker directly reflects the tumor’s biology, making it the most informative indicator in this cancer. Thyroglobulin is produced by follicular cells and is mainly a marker for differentiated thyroid cancers such as papillary or follicular types, so it isn’t reliable for medullary carcinoma. CEA can be elevated in medullary thyroid carcinoma but is nonspecific and less helpful for direct disease monitoring. Calcitonin gene-related peptide isn’t used clinically as a tumor marker for this cancer.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy